Isolated Full Donor T-Cell Chimerism After Haploidentical TCRαβ/CD19 Depleted HSCT Maintains Remission of Familial HLH
- PMID: 38129595
- DOI: 10.1007/s10875-023-01612-6
Isolated Full Donor T-Cell Chimerism After Haploidentical TCRαβ/CD19 Depleted HSCT Maintains Remission of Familial HLH
References
-
- Hartz B, Marsh R, Rao K, Henter JI, Jordan M, Filipovich L, et al. The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis. Blood. 2016;127:3281–90. https://doi.org/10.1182/blood-2015-12-684498 . - DOI - PubMed - PMC
-
- Greental Ness Y, Kuperman AA, Stein J, Yacobovich J, Even-Or E, Zaidman I, et al. Improved transplant outcomes with myeloablative conditioning for hemophagocytic lymphohistiocytosis in HLA-matched and mismatched donors: a national multicenter retrospective study. Bone Marrow Transplant [Internet]. Springer US; 2021; 56:2088–96. https://doi.org/10.1038/s41409-021-01290-1
-
- Sieni E, Cetica V, Hackmann Y, Coniglio ML, Da Ros M, Ciambotti B, et al. Familial hemophagocytic lymphohistiocytosis: When rare diseases shed light on immune system functioning. Front Immunol. 2014;5:1–19. - DOI
-
- Ghosh S, Carmo M, Calero-Garcia M, Ricciardelli I, Bustamante Ogando JC, Blundell MP, et al. T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations. J Allergy Clin Immunol [Internet]. Elsevier Inc.; 2018; 142:904–913.e3. https://doi.org/10.1016/j.jaci.2017.11.050
-
- Weißert K, Ammann S, Kögl T, Dettmer-Monaco V, Schell C, Cathomen T, et al. Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH). EMBO Mol Med. 2022;14(12):e16085. https://doi.org/10.15252/emmm.202216085 . - DOI - PubMed - PMC